Benzo[1,2-c]1,2,5-oxadiazole N-oxide derivatives as potential antitrypanosomal drugs. Structure-activity relationships. Part II. 2002

Gabriela Aguirre, and Hugo Cerecetto, and Rossanna Di Maio, and Mercedes González, and Williams Porcal, and Gustavo Seoane, and Miguel A Ortega, and Ignacio Aldana, and Antonio Monge, and Ana Denicola
Departamento de Química Orgánica, Facultad de Química-Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay.

The preparation of new derivatives of benzo[1,2-c]1,2,5-oxadiazole N-oxide is described. These derivatives were chosen in order to investigate and confirm previous structural features found necessary to display an adequate antitrypanosomal activity. The compounds synthesized were tested in vitro against epimastigote forms of Trypanosoma cruzi. The presence of a bromine atom in the benzo system produced compounds less active than the corresponding de-halo analogues. However, 5-(bromomethyl)-7-bromobenzo[1,2-c]oxadiazole N-oxide (23) was the most cytotoxic compound against T. cruzi. For this, the 50% inhibitory dose (ID50) was determined, it was of the same order as that of Nifurtimox. From statistical analysis we could establish a relationship between lipophilic-hydrophilic balance of the derivatives with their effectiveness as antichagasic compounds.

UI MeSH Term Description Entries
D010069 Oxadiazoles Compounds containing five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom which exist in various regioisomeric forms. Oxadiazole
D003497 Cyclic N-Oxides Heterocyclic compounds in which an oxygen is attached to a cyclic nitrogen. Heterocyclic N-Oxides,Cyclic N Oxides,Heterocyclic N Oxides,N Oxides, Cyclic,N-Oxides, Cyclic,N-Oxides, Heterocyclic,Oxides, Cyclic N
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014344 Trypanocidal Agents Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA. Trypanocidal Drugs,Trypanocides,Trypanosomicidal Agents,Trypanosomicides,Agents, Trypanocidal,Agents, Trypanosomicidal,Drugs, Trypanocidal
D014349 Trypanosoma cruzi The agent of South American trypanosomiasis or CHAGAS DISEASE. Its vertebrate hosts are man and various domestic and wild animals. Insects of several species are vectors. Trypanosoma cruzus,cruzi, Trypanosoma

Related Publications

Gabriela Aguirre, and Hugo Cerecetto, and Rossanna Di Maio, and Mercedes González, and Williams Porcal, and Gustavo Seoane, and Miguel A Ortega, and Ignacio Aldana, and Antonio Monge, and Ana Denicola
June 1999, Journal of medicinal chemistry,
Gabriela Aguirre, and Hugo Cerecetto, and Rossanna Di Maio, and Mercedes González, and Williams Porcal, and Gustavo Seoane, and Miguel A Ortega, and Ignacio Aldana, and Antonio Monge, and Ana Denicola
October 2001, European journal of medicinal chemistry,
Gabriela Aguirre, and Hugo Cerecetto, and Rossanna Di Maio, and Mercedes González, and Williams Porcal, and Gustavo Seoane, and Miguel A Ortega, and Ignacio Aldana, and Antonio Monge, and Ana Denicola
September 2005, Molecules (Basel, Switzerland),
Gabriela Aguirre, and Hugo Cerecetto, and Rossanna Di Maio, and Mercedes González, and Williams Porcal, and Gustavo Seoane, and Miguel A Ortega, and Ignacio Aldana, and Antonio Monge, and Ana Denicola
January 2003, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,
Gabriela Aguirre, and Hugo Cerecetto, and Rossanna Di Maio, and Mercedes González, and Williams Porcal, and Gustavo Seoane, and Miguel A Ortega, and Ignacio Aldana, and Antonio Monge, and Ana Denicola
December 2014, International journal of molecular sciences,
Gabriela Aguirre, and Hugo Cerecetto, and Rossanna Di Maio, and Mercedes González, and Williams Porcal, and Gustavo Seoane, and Miguel A Ortega, and Ignacio Aldana, and Antonio Monge, and Ana Denicola
November 2000, Archiv der Pharmazie,
Gabriela Aguirre, and Hugo Cerecetto, and Rossanna Di Maio, and Mercedes González, and Williams Porcal, and Gustavo Seoane, and Miguel A Ortega, and Ignacio Aldana, and Antonio Monge, and Ana Denicola
November 1998, Die Pharmazie,
Gabriela Aguirre, and Hugo Cerecetto, and Rossanna Di Maio, and Mercedes González, and Williams Porcal, and Gustavo Seoane, and Miguel A Ortega, and Ignacio Aldana, and Antonio Monge, and Ana Denicola
January 2020, Current drug discovery technologies,
Gabriela Aguirre, and Hugo Cerecetto, and Rossanna Di Maio, and Mercedes González, and Williams Porcal, and Gustavo Seoane, and Miguel A Ortega, and Ignacio Aldana, and Antonio Monge, and Ana Denicola
July 2019, Anticancer research,
Gabriela Aguirre, and Hugo Cerecetto, and Rossanna Di Maio, and Mercedes González, and Williams Porcal, and Gustavo Seoane, and Miguel A Ortega, and Ignacio Aldana, and Antonio Monge, and Ana Denicola
June 2021, Journal of medicinal chemistry,
Copied contents to your clipboard!